0000950123-11-033583.txt : 20110407 0000950123-11-033583.hdr.sgml : 20110407 20110407102647 ACCESSION NUMBER: 0000950123-11-033583 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20110407 DATE AS OF CHANGE: 20110407 GROUP MEMBERS: ADAM GRAY GROUP MEMBERS: BLACKWELL PARTNERS, LLC GROUP MEMBERS: CHRISTOPHER SHACKELTON GROUP MEMBERS: COLISEUM CAPITAL MANAGEMENT, LLC GROUP MEMBERS: COLISEUM CAPITAL PARTNERS, L.P. GROUP MEMBERS: COLISEUM CAPITAL, LLC SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: SERACARE LIFE SCIENCES INC CENTRAL INDEX KEY: 0001156295 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 330056054 FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-62043 FILM NUMBER: 11744926 BUSINESS ADDRESS: STREET 1: 37 BIRCH STREET CITY: MILFORD STATE: MA ZIP: 01757 BUSINESS PHONE: 5082446400 MAIL ADDRESS: STREET 1: 37 BIRCH STREET CITY: MILFORD STATE: MA ZIP: 01757 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Coliseum Capital Management, LLC CENTRAL INDEX KEY: 0001409751 IRS NUMBER: 223918079 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 767 THIRD AVENUE STREET 2: 35TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 212-488-5555 MAIL ADDRESS: STREET 1: 767 THIRD AVENUE STREET 2: 35TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 SC 13G 1 c15291sc13g.htm SCHEDULE 13G Schedule 13G

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934
(Amendment No. )*

SeraCare Life Sciences, Inc.
(Name of Issuer)
Common Shares, $.001 par value per share
(Title of Class of Securities)
81747T104
(CUSIP Number)
March 21, 2011
(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     o Rule 13d-1(b)

     þ Rule 13d-1(c)

     o Rule 13d-1(d)

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 
 


 

                     
CUSIP No.
 
81747T104 
 

 

           
1   NAMES OF REPORTING PERSONS
Coliseum Capital Management, LLC
     
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

  (a)   o
  (b)   þ
     
3   SEC USE ONLY
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  Delaware
       
  5   SOLE VOTING POWER
     
NUMBER OF   0
       
SHARES 6   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   1,005,103
       
EACH 7   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   0
       
WITH: 8   SHARED DISPOSITIVE POWER
     
    1,005,103
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  1,005,103
     
10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
   
  o
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
   
  5.2%
     
12   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
   
  OO, IA

Page 2 of 12


 

                     
CUSIP No.
 
81747T104 
 

 

           
1   NAMES OF REPORTING PERSONS
Coliseum Capital, LLC
     
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

  (a)   o
  (b)   þ
     
3   SEC USE ONLY
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  Delaware
       
  5   SOLE VOTING POWER
     
NUMBER OF   0
       
SHARES 6   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   567,497
       
EACH 7   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   0
       
WITH: 8   SHARED DISPOSITIVE POWER
     
    567,497
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  567,497
     
10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
   
  o
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
   
  2.9%
     
12   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
   
  OO

Page 3 of 12


 

                     
CUSIP No.
 
81747T104 
 

 

           
1   NAMES OF REPORTING PERSONS
Coliseum Capital Partners, L.P.
     
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

  (a)   o
  (b)   þ
     
3   SEC USE ONLY
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  Delaware
       
  5   SOLE VOTING POWER
     
NUMBER OF   0
       
SHARES 6   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   567,497
       
EACH 7   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   0
       
WITH: 8   SHARED DISPOSITIVE POWER
     
    567,497
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  567,497
     
10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
   
  o
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
   
  2.9%
     
12   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
   
  PN

Page 4 of 12


 

                     
CUSIP No.
 
81747T104 
 

 

           
1   NAMES OF REPORTING PERSONS
Blackwell Partners, LLC
     
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

  (a)   o
  (b)   þ
     
3   SEC USE ONLY
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  Georgia
       
  5   SOLE VOTING POWER
     
NUMBER OF   0
       
SHARES 6   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   437,606
       
EACH 7   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   0
       
WITH: 8   SHARED DISPOSITIVE POWER
     
    437,606
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  437,606
     
10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
   
  o
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
   
  2.3%
     
12   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
   
  OO

Page 5 of 12


 

                     
CUSIP No.
 
81747T104 
 

 

           
1   NAMES OF REPORTING PERSONS
Adam Gray
     
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

  (a)   o
  (b)   þ
     
3   SEC USE ONLY
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  United States
       
  5   SOLE VOTING POWER
     
NUMBER OF   0
       
SHARES 6   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   1,005,103
       
EACH 7   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   0
       
WITH: 8   SHARED DISPOSITIVE POWER
     
    1,005,103
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  1,005,103
     
10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
   
  o
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
   
  5.2%
     
12   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
   
  IN

Page 6 of 12


 

                     
CUSIP No.
 
81747T104 
 

 

           
1   NAMES OF REPORTING PERSONS
Christopher Shackelton
     
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

  (a)   o
  (b)   þ
     
3   SEC USE ONLY
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  United States
       
  5   SOLE VOTING POWER
     
NUMBER OF   0
       
SHARES 6   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   1,005,103
       
EACH 7   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   0
       
WITH: 8   SHARED DISPOSITIVE POWER
     
    1,005,103
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  1,005,103
     
10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
   
  o
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
   
  5.2%
     
12   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
   
  IN

Page 7 of 12


 

Item 1.
  (a)   Name of Issuer
 
      SeraCare Life Sciences, Inc.
 
  (b)   Address of Issuer’s Principal Executive Offices
 
    37 Birch Street
Milford, MA 01757
Item 2.
  (a)   Name of Person Filing
 
      This Schedule 13G is being filed on behalf of Coliseum Capital Management, LLC (“CCM”), Coliseum Capital, LLC (“CC”), Coliseum Capital Partners, L.P. (“CCP”), Blackwell Partners, LLC (“Blackwell”), Adam Gray (“Gray”) and Christopher Shackelton (“Shackelton” and collectively, the “Reporting Persons”).
 
  (b)   Address of Principal Business office or, if None, Residence
 
      The address of the principal business and office of the Reporting Persons (other than Blackwell) is 767 Third Avenue, 35th Floor, New York, NY 10017. The address of the principal business and office of Blackwell is c/o DUMAC, LLC, 406 Blackwell Street, Suite 300, Durham, NC 27701.
 
  (c)   Citizenship
  (i)   CCM is a Delaware limited liability company
 
  (ii)   CC is a Delaware limited liability company
 
  (iii)   CCP is a Delaware limited partnership
 
  (iv)   Blackwell is a Georgia limited liability company
 
  (v)   Gray is a United States citizen
 
  (vi)   Shackelton is a United States citizen
  (d)   Title of Class Securities
 
      Common Shares, .001 par value per share
 
  (e)   CUSIP Number
 
      81747T104

 

Page 8 of 12


 

Item 3.   If this statement is filed pursuant to §§ 240.13d-1(b), or 240.13d-2(b) or (c), check whether the person filing is a:
  (a)   o Broker or dealer registered under section 15 of the Act (15 U.S.C. 78c).
 
  (b)   o Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
 
  (c)   o Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).
 
  (d)   o Investment company registered under section 8 of the Investment Company Act (15 U.S.C. 80a-8).
 
  (e)   o An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E).
 
  (f)   o An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(ii)(F).
 
  (g)   o A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G).
 
  (h)   o A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813).
 
  (i)   o A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3).
 
  (j)   o Group in accordance with § 240.13d-1(b)(ii)(J).
Item 4.   Ownership
For CCM, Gray and Shackelton:
(a) Amount beneficially owned: 1,005,103
(b) Percent of class: 5.2%*
(c) Number of shares to which CCM, Gray and Shackelton have:
(i) Sole power to vote or to direct the vote: 0
(ii) Shared power to direct the vote: 1,005,103
(iii) Sole power to dispose or to direct the disposition of: 0
(iv) Shared power to dispose or to direct the disposition of: 1,005,103

 

Page 9 of 12


 

For CC and CCP:
(a) Amount beneficially owned: 567,497
(b) Percent of class: 2.9%*
(c) Number of shares to which CC and CCP have:
(i) Sole power to vote or to direct the vote: 0
(ii) Shared power to direct the vote: 567,497
(iii) Sole power to dispose or to direct the disposition of: 0
(iv) Shared power to dispose or to direct the disposition of: 567,497
For Blackwell:
(a) Amount beneficially owned: 437,606
(b) Percent of class: 2.3%*
(c) Number of shares to which Blackwell has:
(i) Sole power to vote or to direct the vote: 0
(ii) Shared power to direct the vote: 437,606
(iii) Sole power to dispose or to direct the disposition of: 0
(iv) Shared power to dispose or to direct the disposition of: 437,606
 
     
*   The ownership percentage of each Reporting Person is calculated based on an assumed total of 19,280,496 Common Shares outstanding as of March 30, 2011, as reported in the Issuer’s Definitive Schedule 14A, as filed with the Securities and Exchange Commission on March 31, 2011.
Item 5.   Ownership of Five Percent or Less of a Class.
  If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class securities, check the following o
Item 6.   Ownership of More than Five Percent on Behalf of Another Person.
  Not applicable.
Item 7.   Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person.
  Not applicable.
Item 8.   Identification and Classification of Members of the Group.

 

Page 10 of 12


 

  The Reporting Persons may be deemed to be members of a group with respect to the Common Shares owned of record by CCP and Blackwell. CCP is the record owner of 567,497 Common Shares and Blackwell is the record owner of 437,606 Common Shares.
Item 9.   Notice of Dissolution of Group.
  Not applicable
Item 10.   Certification:
  By signing below, I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose or with the effect of changing or influencing the control of the issuer and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

 

Page 11 of 12


 

SIGNATURES
After reasonable inquiry and to the best of my knowledge, I certify that the information set forth in this statement is true, complete and correct.
Dated: April 7, 2011
                     
COLISEUM CAPITAL MANAGEMENT, LLC   BLACKWELL PARTNERS, LLC
 
                   
 
      By:   Coliseum Capital Management, LLC,
Attorney-in-fact
       
 
                   
By:
  /s/ Christopher Shackelton   By:   /s/ Adam Gray        
 
                 
 
  Christopher Shackelton, Manager       Adam Gray, Manager        
 
                   
COLISEUM CAPITAL PARTNERS, L.P.   CHRISTOPHER SHACKELTON
 
                   
By:
  Coliseum Capital, LLC, General Partner                
 
                   
By:   /s/ Adam Gray   /s/ Christopher Shackelton
       
    Adam Gray, Manager   Christopher Shackelton
 
                   
COLISEUM CAPITAL, LLC   ADAM GRAY
 
                   
By:
  /s/ Adam Gray   /s/ Adam Gray        
 
                 
 
  Adam Gray, Manager   Adam Gray        

 

Page 12 of 12


 

EXHIBIT A
Joint Filing Agreement Pursuant to Rule 13d-1
This agreement is made pursuant to Rule 13d-l(k)(1) under the Securities and Exchange Act of 1934, as amended (the “Act”) by and among the parties listed below, each referenced to herein as a “Joint Filer.” The Joint Filers agree that a statement of beneficial ownership as required by Sections 13(g) or 13(d) of the Act and the Rules thereunder may be filed on each of their behalf on Schedule 13G or Schedule 13D, as appropriate, and that said joint filing may thereafter be amended by further joint filings. The Joint Filers state that they each satisfy the requirements for making a joint filing under Rule 13d-1.
Date: April 7, 2011
                     
COLISEUM CAPITAL MANAGEMENT, LLC   BLACKWELL PARTNERS, LLC
 
                   
 
      By:   Coliseum Capital Management, LLC,
Attorney-in-fact
       
 
                   
By:
  /s/ Christopher Shackelton   By:   /s/ Adam Gray        
 
                 
 
  Christopher Shackelton, Manager       Adam Gray, Manager        
 
                   
COLISEUM CAPITAL PARTNERS, L.P.   CHRISTOPHER SHACKELTON
 
                   
By:
  Coliseum Capital, LLC, General Partner                
 
                   
By:   /s/ Adam Gray   /s/ Christopher Shackelton
 
                 
    Adam Gray, Manager   Christopher Shackelton
 
                   
COLISEUM CAPITAL, LLC   ADAM GRAY
 
                   
By:
  /s/ Adam Gray   /s/ Adam Gray        
 
                 
 
  Adam Gray, Manager   Adam Gray